Clinical Efficacy and Safety of ‘Oxy +’ in Type 2 Diabetes: A Pilot Study

Md Anzar Alam, Mariyam Ahad, Mohd Aleemuddin Quamri, Fasihur Rehman Ansari, Farooqui Shazia Parveen

Abstract


Background and objectives: Diabetes is a common metabolic disorder.Type 2 diabetes accounts for the vast majority of around 92% of the population worldwide. Long term hyperglycemia leads to macro and microvascular complications. Oxy+ is a nutraceutical capsule which contains mainly Arthrospira (spirulina). Most of the diabetic people use it. Hence a clinical trial was conducted to evaluate the clinical efficacy and safety of Oxy + in Type 2 Diabetes.

Material Methods: The study was designed as a single-blind pilot study; 10 eligible patients of type 2 diabetes were allocated. Oxy+ was given in capsule form; 2 capsules twice daily orally for 45 days after the meal. Test drug was evaluated on subjective parameters at 0th, 15th, 30th and 45th days whereas objective parameters were assessed before and after the treatment. The results of the intervention were analyzed using suitable statistical methods.

Results and Observation:The study effects on subjective parameters like polyuria, tiredness, polyphagia, polydipsia, and Tingling Sensation were found significantly reduced. The objective parameters were assessed before and after as Mean ± SD for FBS (164.4±36.019 vs 111.1±25.075), PPBS (248.5±51.70 vs 170.1±45.148) and HbA1c (9.14±1.517 vs 6.95±1.224).The results were analyzed after using paired‘t’ test.

Interpretation and Conclusion:The findings about both parameters (subjective and objective) that the ‘Oxy+’ is effective in type 2 diabetes and the cure was considerable. Safety parameters (SGOT, SGPT, Blood Urea, and Serum Creatinine) were remained unchanged. Therefore, it can be concluded that the ‘Oxy+’ would be safe and effective in the management of type 2 diabetes.

International Journal of Human and Health Sciences Vol. 05 No. 01 January’21 Page: 96-100


Keywords


Type 2 Diabetes; Oxy+; metabolic disorder; nutraceutical; Arthrospira (spirulina)

Full Text:

PDF


DOI: http://dx.doi.org/10.31344/ijhhs.v5i1.241

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Md Anzar Alam, Mariyam Ahad, Mohd Aleemuddin Quamri, Fasihur Rehman Ansari, Farooqui Shazia Parveen

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.